THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS

被引：0
|
作者：
Arita, Kazuko [1 ]
Tanabe, Takehiro [1 ]
Kihara, Emi [1 ]
Maeda, Katsutoshi [1 ]
Oda, Hiroaki [1 ]
Doi, Shigehiro [2 ]
Masaki, Takao [2 ]
机构：
[1] Oda Naika Clin, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Hiroshima, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP719
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [21] Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) on Lipid Metabolism and Insulin Resistance in Human
    Muraki, Isao
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (04) : 317 - 318
  • [22] Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders
    Yildirim, A. M.
    Koca, A. O.
    Beyan, E.
    Dogan, O.
    Karakaya, S.
    Aksoz, Z.
    Ertugrul, D. T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (17) : 5511 - 5517
  • [23] Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
    Bao, Xuhui
    Liang, Yongjun
    Chang, Hanman
    Cai, Tianji
    Feng, Baijie
    Gordon, Konstantin
    Zhu, Yuekun
    Shi, Hailian
    He, Yundong
    Xie, Liyi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [24] Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse
    Saeed, Anum
    Virani, Salim S.
    Jones, Peter H.
    Ballantyne, Christie M.
    Nambi, Vijay
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (05) : 1141 - 1145
  • [25] Role and regulation of the proprotein convertase subtilisin/kexin type 9 (PCSK9) in the small intestine
    Leblond, Francois
    Precourt, Louis-Philippe
    Delvin, Edgard
    Elchebly, Mounib
    Seidah, Nabil
    Ziv, Ehud
    Levy, Emile
    FASEB JOURNAL, 2008, 22
  • [26] Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
    Xuhui Bao
    Yongjun Liang
    Hanman Chang
    Tianji Cai
    Baijie Feng
    Konstantin Gordon
    Yuekun Zhu
    Hailian Shi
    Yundong He
    Liyi Xie
    Signal Transduction and Targeted Therapy, 9
  • [27] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
    O'Connell, Emma M.
    Lohoff, Falk W.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [28] Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis
    Lu, Xinjie
    CURRENT DRUG TARGETS, 2019, 20 (10) : 1029 - 1040
  • [29] PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
    Shimada, Yuichi J.
    Cannon, Christopher P.
    EUROPEAN HEART JOURNAL, 2015, 36 (36) : 2415 - U36
  • [30] Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
    Bhattacharya, Anindita
    Chowdhury, Abhirup
    Chaudhury, Koel
    Shukla, Praphulla Chandra
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
12345